[Anti-platelet aggregation therapy and ischaemic cerebral accidents due to atheroma (author's transl)].
Most controlled studies of the effects of anticoagulants on ischaemic cerebral accidents due to atheroma were carried out in the 60's and failed to show long-term beneficial results. Anti-platelet aggregation agents, such as dipyridamole, clofibrate and sulfinpyrazone, did not prove more effective. A well-conducted co-operative Canadian study has recently shown that aspirin in doses of 1300 mg/day reduced by 19% the risk of ischaemic cerebral accident or death and that this risk is further reduced in the subgroup of non-diabetic male patients without history of infarction. Another American co-operative study suggests that aspirin is more effective in patients who had several transient episodes of cerebral ischaemia and that an atheromatous lesion is present. No combination of anti-platelet aggregation agents is demonstrably superior to aspirin. The present tendency is to administer heparin immediately after ischaemic cerebral accidents.